Lmr Partners LLP Cti Biopharma Corp Transaction History

Lmr Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.55 - $6.27 $255,308 - $450,925	-71,918 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.9 - $5.23 $136,644 - $376,131	71,918 New	71,918 $336,000
Q2 2021 Aug 16, 2021	SELL	$2.16 - $2.62 $81,581 - $98,954	-37,769 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.68 - $3.8 $101,220 - $143,522	37,769 New	37,769 $110,000
Q4 2019 Feb 14, 2020	SELL	$0.72 - $1.64 $39,550 - $90,086	-54,931 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.8 - $1.03 $43,944 - $56,578	54,931 New	54,931 $47,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.